Literature DB >> 26401257

Longitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry.

Andrew J Swift1, Smitha Rajaram2, Dave Capener2, Charlie Elliot3, Robin Condliffe3, Jim M Wild2, David G Kiely3.   

Abstract

Right ventricular (RV) function is a strong predictor of outcome in cardiovascular diseases. Two components of RV function, longitudinal and transverse motion, have been investigated in pulmonary hypertension (PH). However, their individual clinical significance remains uncertain. The aim of this study was to determine the factors associated with transverse and longitudinal RV motion in patients with PH. In 149 treatment-naive patients with PH and 16 patients with suspected PH found to have mean pulmonary arterial pressure of <20 mmHg, cardiovascular magnetic resonance imaging was performed within 24 hours of right heart catheterization. In patients with PH, fractional longitudinal motion (fractional tricuspid annulus to apex distance [f-TAAD]) was significantly greater than fractional transverse motion (fractional septum to free wall distance [f-SFD]; P = 0.002). In patients without PH, no significant difference between f-SFD and f-TAAD was identified (P = 0.442). Longitudinal RV motion was singularly associated with RV ejection fraction independent of age, invasive hemodynamics, and cardiac magnetic resonance measurements (P = 0.024). In contrast, transverse RV motion was independently associated with left ventricular eccentricity (P = 0.036) in addition to RV ejection fraction (P = 0.014). In conclusion, RV motion is significantly greater in the longitudinal direction in patients with PH, whereas patients without PH have equal contributions of transverse and longitudinal motion. Longitudinal RV motion is primarily associated with global RV pump function in PH. Transverse RV motion not only reflects global pump function but is independently influenced by ventricular interaction in patients with PH.

Entities:  

Keywords:  magnetic resonance imaging; pulmonary hypertension; right ventricle

Year:  2015        PMID: 26401257      PMCID: PMC4556507          DOI: 10.1086/682428

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  22 in total

1.  Longitudinal shortening accounts for the majority of right ventricular contraction and improves after pulmonary vasodilator therapy in normal subjects and patients with pulmonary arterial hypertension.

Authors:  Suzanne B Brown; Amresh Raina; David Katz; Molly Szerlip; Susan E Wiegers; Paul R Forfia
Journal:  Chest       Date:  2010-11-24       Impact factor: 9.410

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

3.  Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Dan Hagger; Robin Condliffe; Neil Woodhouse; Charlie A Elliot; Iain J Armstrong; Christine Davies; Catherine Hill; Mohammed Akil; Jim M Wild; David G Kiely
Journal:  Rheumatology (Oxford)       Date:  2009-07-14       Impact factor: 7.580

4.  ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.

Authors:  J Hurdman; R Condliffe; C A Elliot; C Davies; C Hill; J M Wild; D Capener; P Sephton; N Hamilton; I J Armstrong; C Billings; A Lawrie; I Sabroe; M Akil; L O'Toole; D G Kiely
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

5.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

6.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

7.  Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension.

Authors:  Gert-Jan Mauritz; Taco Kind; J Tim Marcus; Harm-Jan Bogaard; Mariëlle van de Veerdonk; Pieter E Postmus; Anco Boonstra; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Chest       Date:  2011-09-29       Impact factor: 9.410

8.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

9.  New predictors of outcome in idiopathic pulmonary arterial hypertension.

Authors:  Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; Robert P Garofano; Rochelle L Goldsmith; Allison C Widlitz; Erika B Rosenzweig; Diane Kerstein; Robyn J Barst
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

10.  Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.

Authors:  Andrew J Swift; Smitha Rajaram; Michael J Campbell; Judith Hurdman; Steve Thomas; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792

View more
  5 in total

1.  Regional contribution to ventricular stroke volume is affected on the left side, but not on the right in patients with pulmonary hypertension.

Authors:  E Ostenfeld; S S Stephensen; K Steding-Ehrenborg; E Heiberg; H Arheden; G Rådegran; J Holm; M Carlsson
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-03       Impact factor: 2.357

2.  A graph theoretic approach for computing 3D+time biventricular cardiac strain from tagged MRI data.

Authors:  Ming Li; Himanshu Gupta; Steven G Lloyd; Louis J Dell'Italia; Thomas S Denney
Journal:  Med Image Anal       Date:  2016-06-11       Impact factor: 8.545

3.  Quantification of the relative contribution of the different right ventricular wall motion components to right ventricular ejection fraction: the ReVISION method.

Authors:  Bálint Lakatos; Zoltán Tősér; Márton Tokodi; Alexandra Doronina; Annamária Kosztin; Denisa Muraru; Luigi P Badano; Attila Kovács; Béla Merkely
Journal:  Cardiovasc Ultrasound       Date:  2017-03-27       Impact factor: 2.062

4.  Left ventricular end-diastolic dimension and septal e' are predictors of cardiac index at rest, while tricuspid annular plane systolic excursion is a predictor of peak oxygen uptake in patients with pulmonary hypertension.

Authors:  Yoshihisa Nakano; Naoki Okumura; Shiro Adachi; Shigetake Shimokata; Fumitaka Tajima; Yoshihiro Kamimura; Toyoaki Murohara; Takahisa Kondo
Journal:  Heart Vessels       Date:  2017-11-15       Impact factor: 2.037

5.  Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction.

Authors:  Pankaj Garg; Robert A Lewis; Christopher S Johns; Andrew J Swift; David Capener; Smitha Rajaram; A A Roger Thompson; Robin Condliffe; Charlie A Elliot; Athanasios Charalampopoulos; Abdul G Hameed; Alexander Rothman; Jim M Wild; David G Kiely
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-12       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.